Basilea Pharmaceutica files claims against Johnson&Johnson over
Basilea Pharmaceutica Ltd. announces that it has filed claims in arbitration against Johnson&Johnson, and affiliated companies related to delays in approval of ceftobiprole.
Basilea Pharmaceutica AG / Basilea awarded USD 130 million by arbitral tribunal Processed and transmitted by Thomson Reuters.